Table 4.
Odds of Completing Colonoscopy Within 90 Days of Positive FIT/gFOBT by Race/Ethnicity: PROSPR Cohort 2010–2012
Follow-up Colonoscopya % | AORb | 95% CI | AORc | 95% CI | |
---|---|---|---|---|---|
Overall | N=59,928 | ||||
Non-Hispanic white | 56.2 | 1.00 | (ref) | 1.00 | (ref) |
Non-Hispanic black | 51.9 | 0.85 | 0.80–0.90 | 0.94 | 0.88–1.00 |
Hispanic | 57.0 | 1.00 | 0.95–1.04 | 1.05 | 1.00–1.10 |
Asian/Pacific Islander | 54.2 | 0.89 | 0.85–0.94 | 0.87 | 0.82–0.91 |
American Indian/Alaska Native | 47.1 | 0.66 | 0.54–0.83 | 0.68 | 0.56–0.83 |
Multiple/other | 50.0 | 0.81 | 0.72–0.91 | 0.83 | 0.74–0.93 |
Colonoscopy within 90 days of a positive FIT/gFOBT
Adjusted for age, sex, length of prior enrollment, and study site
Adjusted for age, sex, study site, length of prior enrollment, ZIP code median income type of residence, insurance type, and Charlson co-morbidity score
FIT, fecal immunochemical test; FOBT, fecal occult blood test; PROSPR, Population-based Research Optimizing Screening through Personalized Regimens